COO at Neuro-Bio

2 weeks ago


Oxford Oxfordshire, United Kingdom OBN Ltd Full time

Neuro-Bio is a privately owned biotech, near Oxford UK, developing a disruptive approach to diagnosis and treatment of Alzheimer's and other neuro-degenerative diseases, based on the work of Baroness Professor Susan Greenfield and colleagues. Existing marketed therapies for Alzheimer’s disease target symptoms in the late stages, but don’t arrest the core problem: hence to date all attempts to develop a truly effective treatment have failed. A new approach, such as that being pioneered by Neuro-Bio, is urgently needed.

The COO will play a critical role in driving the pre-IND activity. We require an experienced energetic individual who excels in a highly dynamic environment to help shape the Company’s future through his/her strategic contributions.

For more information please refer to the associated pdf.

By clicking the Accept button, you agree to us doing so.

#J-18808-Ljbffr
  • COO at Neuro-Bio

    2 weeks ago


    Oxford, Oxfordshire, United Kingdom OBN Ltd Full time

    Neuro-Bio is a privately owned biotech, near Oxford UK, developing a disruptive approach to diagnosis and treatment of Alzheimer's and other neuro-degenerative diseases, based on the work of Baroness Professor Susan Greenfield and colleagues. Existing marketed therapies for Alzheimer’s disease target symptoms in the late stages, but don’t arrest the...


  • Oxford, Oxfordshire, United Kingdom OBN Ltd Full time

    Neuro-Bio is a privately owned biotech, near Oxford UK, developing a disruptive approach to diagnosis and treatment of Alzheimer's and other neuro-degenerative diseases, based on the work of Baroness Professor Susan Greenfield and colleagues. Existing marketed therapies for Alzheimer’s disease target symptoms in the late stages, but don’t arrest the core...